Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis

Krzysztof Szymanowski 1, Mateusz Mikołajczyk 2, Przemysław Wirstlein 2, Anna Dera-Szymanowska 3
1 - Department of Mother’s and Child’s Health, Poznań University of Medical Sciences, Poland
2 - Department of Obstetrics and Gynecology, Division of Reproduction, Poznań University of Medical Sciences, Poland
3 - Department of Perinatology and Gynecology, Poznań University of Medical Sciences, Poland
Ann Agric Environ Med
2016; 23 (4):
ICID: 1226861
Article type: Original article
Introduction. The prevalence of endometriosis among reproductive age women is 7–17%; however, these figures reach 20–50% in patients suffering from infertility. Matrix metalloproteinases (MMPs) activity is thought to be particularly essential in the early phases of endometriosis development. Any changes in the equilibrium between MMPs activity and their tissue inhibitors (TIMPs) could be potentially harmful, promoting endometriosis development. The aim of this study was to investigate whether the MMP-2, MMP-9, TIMP-1 or TGF-B2 expression in eutopic endometrium from women with early endometriosis differ when compared with healthy subjects. The results were referred to the serum progesterone levels.
Materials and method. Endometrial biopsy was taken from 42 patients (18 in the study group, 22 in thecontrol group) at the time of hysteroscopy for routine histology and for RT-PCR procedures. Comparison of the quantity of gene products was performed with a programme for densitometry and compared to GADPH product, which was a reference value.
Results. The obtained results did not reveal any statistical difference in endometrial expression of MMP-2, MMp-9, TIMP-1, and TGF-β2 or serum progesterone level between women with endometriosis and without visible signs of this illness.
Conclusion. Despite the lack of statistical differences, it was observed that both examined metalloproteinases expressed a tendency to higher gene expression in the eutopic endometrium of women with endometriosis. However, both TIMP-1 and TGF-β2 expressions had the same tendency – higher values in endometriosis patients.
DOI: 10.5604/12321966.1226861
PMID 28030938 - click here to show this article in PubMed

Recommend this article to:


Related articles in IndexCopernicus™
     tissue inhibitors of metalloproteinases [2 related records]
     matrix metalloproteinases [2 related records]
     Endometriosis [130 related records]


Related articles

, ,
 OBJECTIVES Chronic pelvic pain (CPP) is best defined as non-menstrual pelvic pain for at least six months, which is severe enough to cause functional disability and require medical or surgical treatment. A thorough clinical examination no do...
M Malec-Milewska, B Horosz,
Pharmacological treatment and regional anesthesia...
Introduction. Chronic pelvic pain syndrome occurs in 4–14% of women. Pain pathomechanism in this syndrome is complex, as it is common to observe the features of nociceptive, inflammatory, neuropathic and psychogenic pain. The common findings in wom...
P Skowrońska, E Pastuszek,
The role of vitamin D in reproductive dysfunction ...
Vitamin D is essential for the proper functioning of the human body. There is also evidence of its strong association with fertility problems in women. This review aims to evaluate the relationship between vitamin D and diseases affecting women’s f...